Insider Trading March 5, 2026

Oklo Co-Founder Caroline Cochran Disposes $12.66 Million in Shares

Sales executed under a prearranged 10b5-1 plan as company advances Meta nuclear agreement and attracts analyst upgrades

By Maya Rios OKLO
Oklo Co-Founder Caroline Cochran Disposes $12.66 Million in Shares
OKLO

Caroline Cochran, co-founder and chief operating officer of Oklo Inc. (OKLO), sold Class A common shares on March 2, 2026, in transactions totaling $12,658,097. The sales were carried out under a Rule 10b5-1 trading plan adopted March 31, 2025. The moves come amid significant corporate developments for Oklo, including a binding agreement with Meta for a phased 1.2 GW advanced nuclear campus and subsequent analyst coverage changes.

Key Points

  • Cochran sold Class A common shares on March 2, 2026, totaling $12,658,097 under a Rule 10b5-1 trading plan - impacts corporate governance and insider activity monitoring.
  • Oklo’s shares have risen 117% over the past year and were trading at $65.65; InvestingPro analysis flagged the stock as appearing overvalued - relevant to equity investors and market analysts.
  • Oklo announced a binding agreement with Meta for a phased 1.2 GW advanced nuclear campus, prompting upgrades and coverage changes from multiple broker-dealers - significant for energy, utilities and corporate procurement sectors.

Caroline Cochran, co-founder and chief operating officer of Oklo Inc. (EXCHANGE: OKLO), disclosed sales of Class A common stock on March 2, 2026, with aggregate proceeds totaling $12,658,097.

The transactions were executed at prices spanning $60.4413 to $64.3271 per share. Cochran sold multiple lots directly and indirectly; the direct dispositions consisted of 5,950 shares, 16,670 shares, 9,330 shares, 24,210 shares, 3,839 shares and 40,000 shares. In a parallel set of indirect sales, 5,951 shares, 16,670 shares, 9,329 shares, 24,211 shares, 3,840 shares and 40,000 shares were sold through Jacob DeWitte and the Caroline Cochran GRAT.

Those sales were completed under a pre-arranged Rule 10b5-1 trading plan that Cochran adopted on March 31, 2025. After the March 2 transactions, Cochran retains direct ownership of 733,073 shares of Oklo Inc. Class A common stock.

The timing of the sales follows a strong run for Oklo's shares - the stock has returned 117% over the past year and was trading at $65.65 at the time of the report. An InvestingPro analysis cited in the filing indicates the stock appears overvalued at current levels.

Oklo has been the center of several notable corporate developments recently. The company announced a binding agreement with Meta to develop a phased 1.2 gigawatt advanced nuclear campus. That announcement triggered a wave of broker activity:

  • BofA Securities upgraded Oklo's rating from Neutral to Buy and raised its price target to $127.00.
  • Wedbush maintained an Outperform rating with a $150.00 price target, referencing Oklo's role in Meta's broader plans for up to 6.6 gigawatts of new nuclear projects.
  • Texas Capital Securities initiated coverage with a Buy rating and a $138.00 price target, highlighting the potential of Oklo's Aurora reactor technology.
  • UBS reiterated a Neutral rating with a $95.00 price target following the long-term agreement with Meta covering up to 1.2 gigawatts of Oklo powerhouses by 2034; that agreement includes customer prepayments intended to fund early development phases.

Market interest in nuclear-related equities strengthened after public comments in support of nuclear power by President Donald Trump at the World Economic Forum in Davos, a development that helped nuclear stocks, including Oklo, gain traction.

While the insider sales are notable for their size and timing, they were executed under a previously established trading plan. The corporate milestones and analyst reactions cited above provide additional context for investor attention on Oklo as it pursues commercial agreements and advances its technology.


Summary of transaction specifics:

  • Date of sale: March 2, 2026.
  • Total proceeds: $12,658,097.
  • Price range: $60.4413 to $64.3271 per share.
  • Structure: Multiple direct and indirect lots sold; transactions conducted under a Rule 10b5-1 plan adopted March 31, 2025.
  • Post-sale direct holdings: 733,073 Class A shares.

Risks

  • Insider sales occurred under a pre-arranged 10b5-1 plan - while routine, such planned sales can create short-term selling pressure or alter market perceptions of insider conviction; relevant to equity markets and investor sentiment.
  • Valuation concerns cited by InvestingPro - the stock was described as appearing overvalued at current levels, introducing uncertainty for prospective buyers and portfolio managers focused on fundamentals.
  • Execution risk for large, long-term projects such as the phased 1.2 GW Meta agreement - the arrangement depends on development milestones and funding mechanics including customer prepayments, which affects project finance and power sector stakeholders.

More from Insider Trading

Colony Bankcorp Chief Banking Officer Adds to Personal Stake, Transactions Total $20,125 Mar 5, 2026 10x Genomics CEO Disposes of $367,096 in Stock as Shares Hover Near Yearly High Mar 5, 2026 Isabella Bank CCO Jon Catlin Buys Shares as Firm Announces Dividend, New CFO and Upgraded Price Target Mar 5, 2026 Newmont Executive Disposes $164,381 in Stock Under 10b5-1 Plan Mar 5, 2026 Peoples Bancorp Director Sells 477 Shares; Holds Significant Direct and Indirect Stakes Mar 5, 2026